Old Web
English
Sign In
Acemap
>
Paper
>
The KRAS Variant as a Predictive Biomarker of Cetuximab Response in Head and Neck Cancer
The KRAS Variant as a Predictive Biomarker of Cetuximab Response in Head and Neck Cancer
2017
Jeffrey P. Bruce
Wei Xu
Fei-Fei Liu
Keywords:
Cetuximab
KRAS
Cancer research
Biomarker (medicine)
Head and neck cancer
Oncology
Internal medicine
Medicine
Proto-Oncogene Proteins p21(ras)
predictive biomarker
Correction
Source
Cite
Save
Machine Reading By IdeaReader
6
References
0
Citations
NaN
KQI
[]